Kronos Bio
KRON
KRON was delisted on the 20th of June, 2025.
47 hedge funds and large institutions have $15.8M invested in Kronos Bio in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.18% less ownership
Funds ownership: 32.56% → 31.38% (-1.2%)
15% less capital invested
Capital invested by funds: $18.7M → $15.8M (-$2.88M)
16% less funds holding
Funds holding: 56 → 47 (-9)
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
+$887K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$329K |
| 3 |
DCM
Deuterium Capital Management
Clearwater,
Florida
|
+$141K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$286K |
| 2 |
Millennium Management
New York
|
-$281K |
| 3 |
CIA
Choate Investment Advisors
Boston,
Massachusetts
|
-$261K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$180K |
| 5 |
GS
Gilead Sciences
Foster City,
California
|
-$179K |
KRON Hedge Fund Activity: Q1 2025 in Review
47 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q1 2025, worth a combined $15.8M — down 15% from $18.7M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of KRON and 4 opened new positions — a net loss of 9 holders — while 14 trimmed existing stakes and 9 added.
The largest buyer was Partners Capital Investment Group, adding an estimated $887K. The largest seller was Jacobs Levy Equity Management, exiting entirely with an estimated $286K sold.
- 47 institutional investors held Kronos Bio (KRON) as of Q1 2025, down from 56 in Q4 2024.
- Funds reported $15.8M of Kronos Bio stock for Q1 2025, down 15% quarter-over-quarter.
- 4 funds opened new Kronos Bio positions in Q1 2025 and 13 closed out, a net change of -9 holders.
- The largest Kronos Bio buyer in Q1 2025 was Partners Capital Investment Group, an estimated $887K added.
- The largest Kronos Bio seller in Q1 2025 was Jacobs Levy Equity Management, an estimated $286K sold.
Based on aggregated 13F filings for Q1 2025.